openPR Logo
Press release

Global Enasidenib Market Developments, Trends & Growth Forecast at impressive CAGR during the Forecast Period 2018 – 2025

11-26-2018 02:04 PM CET | Health & Medicine

Press release from: Market Research Hub

Market Research Hub

Market Research Hub

Looking at the current trends across the Enasidenib market, a new study has been included to the wide database of Market Research Hub (MRH). The assessment is titled "Global Enasidenib Market Insights, Forecast to 2025", which discourses the various market impacting factors like drivers, restraints and opportunities. Moreover, readers are informed about the competitive landscape which enlightens about the different players operating in the Enasidenib market together with their market value. Enasidenib is a drug used to treat relapsed or refractoryacute myeloid leukemiain people with specific mutations of theisocitrate dehydrogenase 2(IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test

Request for free Sample @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1934287

In 2017, the global Enasidenib market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Enasidenib market based on company, product type, application and key regions.

This report studies the global market size of Enasidenib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Enasidenib in these regions.
This research report categorizes the global Enasidenib market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Enasidenib include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Enasidenib include
Celgene Corporation

Market Size Split by Type
50mg
100mg
Market Size Split by Application
Hospital
Pharmacy

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

In this study, the years considered to estimate the market size of Enasidenib are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Enasidenib market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-enasidenib-market-insights-forecast-to-2025-report.html

Table of Contents

1 Study Coverage
1.1 Enasidenib Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Enasidenib Market Size Growth Rate by Type
1.4.2 50mg
1.4.3 100mg
1.5 Market by Application
1.5.1 Global Enasidenib Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Enasidenib Market Size
2.1.1 Global Enasidenib Revenue 2016-2025
2.1.2 Global Enasidenib Sales 2016-2025
2.2 Enasidenib Growth Rate by Regions
2.2.1 Global Enasidenib Sales by Regions
2.2.2 Global Enasidenib Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Enasidenib Sales by Manufacturers
3.1.1 Enasidenib Sales by Manufacturers
3.1.2 Enasidenib Sales Market Share by Manufacturers
3.1.3 Global Enasidenib Market Concentration Ratio (CR5 and HHI)
3.2 Enasidenib Revenue by Manufacturers
3.2.1 Enasidenib Revenue by Manufacturers (2016-2018)
3.2.2 Enasidenib Revenue Share by Manufacturers (2016-2018)
3.3 Enasidenib Price by Manufacturers
3.4 Enasidenib Manufacturing Base Distribution, Product Types
3.4.1 Enasidenib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Enasidenib Product Category
3.4.3 Date of International Manufacturers Enter into Enasidenib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

Continue...@@$

Enquire about this Report - https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1934287

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : press@marketresearchhub.com
Website : www.marketresearchhub.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Enasidenib Market Developments, Trends & Growth Forecast at impressive CAGR during the Forecast Period 2018 – 2025 here

News-ID: 1399241 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for Enasidenib

Enasidenib Market Development, Industry Trends, Demand and Growth Analysis and F …
The global Enasidenib market was valued at approximately USD 78 million in 2023 and is projected to reach USD 125.9 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/enasidenib-market Enasidenib Market Overview: The Enasidenib market is primarily driven by the increasing prevalence of acute myeloid leukemia (AML), specifically in patients with an IDH2 mutation. Enasidenib, a targeted
Global Enasidenib Market Estimated to Experience a Hike in Growth by 2031
The global Enasidenib market was valued at approximately USD 87.9 million in 2023 and is projected to reach around USD 151.8 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031. Global Enasidenib Market Overview The global enasidenib market is experiencing steady growth, driven by its effectiveness in treating relapsed or refractory acute myeloid leukemia (AML) with IDH2 mutations. In 2023, the market
Enasidenib Market Analysis, Size, Current Scenario and Future Prospects
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. Enasidenib Market research report allows making important decision making essential for business growth. It helps key
2022 Enasidenib Market Report- by Key Segments, Growth Size, Emerging Trends and …
Enasidenib Market report incorporates item types, market applications, geographic areas, and financial backers and providers. The overall statistical surveying gives a complete investigation of the business for the figure time frame. In addition, the examination incorporates a few divisions just as a full investigation of the market's patterns and critical determinants. Moreover, Enasidenib Market report assists you in overcoming the difficulties by applying various strategies. Download FREE PDF of the Report
Global Enasidenib Market, Size, Share, Analysis Report & Forecast to 2026
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. AML is a form of blood cancer, that starts in the bone marrow and
Global Enasidenib Drugs Market Report 2018-2025 | Segmantation by Industry Surve …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test In 2018, the global Enasidenib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the